AR-mediated metabolic reprogramming promotes proliferation of prostate cancer cells by positively regulating anabolic metabolism and lipogenesis (Barfeld et al. 2014; Bader and McGuire 2020; Ahmad et al. 2021). The gene discussed is AR; the disease is prostate cancer.